Patent · US Active

Subcutaneous formulations of anti-CD38 antibodies and their uses

US10385135B2 · kind B2 · utility

17Cited by
10References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2016
Grant dateAug 20, 2019
Priority date—
Expiry dateNov 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.